Enantiomerically pure phosphonated carbocyclic 2′-Oxa-3′-azanucleosides: Synthesis and biological evaluation

Molecules

Volumn 19, Issue 9, 2014, Pages 14406-14416

  Romeo, Roberto ^a   Carnovale, Caterina ^a   Giofrè, Salvatore V ^a   Monciino, Giulia ^b   Chiacchio, Maria A ^b   Sanfilippo, Claudia ^c   Macchi, Beatrice ^d  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Antiretroviral; N,O modified nucleosides; PCOANs

Indexed keywords

NUCLEOSIDE; PHOSPHONIC ACID DERIVATIVE;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS; U937 CELL LINE; VIROLOGY;

HIV; HIV INFECTIONS; HUMANS; MOLECULAR STRUCTURE; NUCLEOSIDES; ORGANOPHOSPHONATES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; U937 CELLS;

EID: 84907090605     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190914406     Document Type: Article

References (55)

1. Li, X.; Zhan, P.; de Clercq, E.; Liu, X. The HIV-1 non-nucleoside reverse transcriptase inhibitors (Part 5): Capravirine and its analogues. Curr. Med. Chem. 2012, 19, 6138-6149.
2. Saag, M.S. New and investigational antiretroviral drugs for HIV infection: Mechanisms of action and early research findings. Top. Antivir. Med. 2012, 20, 162-167.
3. De Clercq, E. Highlights in the discovery of antiviral drugs: A personal retrospective. J. Med. Chem. 2010, 53, 1438-1450.
4. Mehellou, Y.; de Clercq, E. Twenty-six years of anti-HIV drug discovery: Where do we stand and where do we go. J. Med. Chem. 2010, 53, 521-538.
5. Stambasky, J.; Hocek, M.; Kocovsky, P. C-nucleosides: Synthetic strategies and biological applications. Chem. Rev. 2009, 109, 6729-6764.
6. Galmarini, C.M.; Popowycz, F.; Joseph, B. Cytotoxic nucleoside analogues: Different strategies to improve their clinical efficacy. Curr. Med. Chem. 2008, 15, 1072-1082.
7. Kool, E.T. Modified DNA bases: Probing base-pair recognition by polymerases. Modified nucleosides. In Biochemistry, Biotechnology and Medicine; Herdewijn, P., Ed.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2008.
8. Balestrieri, E.; Matteucci, C.; Ascolani, A.; Piperno, A.; Romeo, R.; Romeo, G.; Chiacchio, U.; Mastino, A.; Macchi, B. Effect of phosphonated carbocyclic 2′-oxa-3′-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro. Antimicrob. Agents Chemother. 2008, 52, 54-64.
9. De Clercq, E. New approaches toward anti-HIV chemotherapy. J. Med. Chem. 2005, 48, 1297-1313.
10. Sari, O.; Roy, V.; Agrofoglio, L.A. Nucleosides modified at the base moiety. In Chemical Synthesis of Nucleoside Analogues, 1st ed.; Merino, P., Ed.; Wiley-VCH: Hoboken, NJ, USA, 2013; p. 49.
11. Romeo, R.; Carnovale, C.; Rescifina, A.; Chiacchio, M.A. Phosphonated nucleoside analogues. In Chemical Synthesis of Nucleoside Analogues, 1st ed.; Merino, P., Ed.; Wiley-VCH: Hoboken, NJ, USA, 2013; p. 163.
12. Chiacchio, U.; Corsaro, A.; Giofrè, S.V.; Romeo, G. Isoxazolidinyl nucleosides. In Chemical Synthesis of Nucleoside Analogues, 1st ed.; Merino, P., Ed.; Wiley-VCH: Hoboken, NJ, USA, 2013; p. 781.
13. Peyrottes, S.; Perigaud, C. Mononucleotide prodrug synthetic strategies. In Chemical Synthesis of Nucleoside Analogues, 1st ed.; Merino, P., Ed.; Wiley-VCH: Hoboken, NJ, USA, 2013; p. 229.
14. Mitsuya, H.; Weinhold, K.J.; Furman, P.A.; St. Clair, M.H.; Lehrman, S.N.; Gallo, R.C.; Bolognesi, D.; Barry, D.W.; Broder, S. 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA 1985, 82, 7096-7100.
15. Mitsuya, H.; Broder, S. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA 1986, 83, 1911-1915.
16. Romeo, G.; Chiacchio, U.; Corsaro, A.; Merino, P. Chemical synthesis of heterocyclic-sugar nucleoside analogues. Chem. Rev. 2010, 110, 3337-3370.
17. Chiacchio, U.; Padwa, A.; Romeo, G. Cycloaddition methodology: A useful entry towards biologically active heterocycle. Curr. Org. Chem. 2009, 13, 422-443.
18. Piperno, A.; Chiacchio, M.A.; Iannazzo, D.; Romeo, R. Synthesis and biological activity of phosphonated nucleosides: Part 1. Furanose, carbocyclic and heterocyclic analogues. Curr. Med. Chem. 2006, 13, 3675-3695.
19. Merino, P.; Tejero, T.; Unzurrunzaga, F.J.; Franco, S.; Chiacchio, U.; Saita, M.G.; Iannazzo, D.; Piperno, A.; Romeo, G. An efficient approach to enantiomeric isoxazolidinyl analogues of tiazofurin based on nitrone cycloadditions. Tetrahedron Asymmetry 2005, 16, 3865-3876.
20. Chiacchio, U.; Genovese, F.; Iannazzo, D.; Librando, V.; Merino, P.; Rescifina, A.; Romeo, R.; Procopio, A.; Romeo, G. Diastereoselective synthesis of homo-N,O-nucleosides. Tetrahedron 2004, 60, 441-448.
21. Chiacchio, U.; Corsaro, A.; Iannazzo, D.; Piperno, A.; Pistarà, V.; Rescifina, A.; Romeo, R.; Sindona, G.; Romeo, G. Diastereo- and enantioselective synthesis of N,O-nucleosides. Tetrahedron Asymmetry 2003, 14, 2717-2723.
22. Chiacchio, U.; Corsaro, A.; Mates, J.; Merino, P.; Piperno, A.; Rescifina, A.; Romeo, G.; Tejero, T. Isoxazolidine analoguese of pseudouridine: A new class of modified nucleosides. Tetrahedron 2003, 59, 4733-4738.
23. Chiacchio, U.; Corsaro, A.; Pistarà, V.; Rescifina, A.; Iannazzo, D.; Piperno, A.; Romeo, G.; Romeo, R.; Grassi, G. Diastereoselective synthesis of N,O-psiconucleosides, a new class of modified nucleosides. Eur. J. Org. 2002, 7, 1206-1212.
24. Chiacchio, U.; Corsaro, A.; Iannazzo, D.; Piperno, A.; Procopio, A.; Rescifina, A.; Romeo, G.; Romeo, R. A stereoselective approach to isoxazolidinyl nucleosides. Eur. J. Org. Chem. 2001, 10, 1893-1898.
25. Chiacchio, U.; Gumina, G.; Rescifina, A.; Romeo, R.; Uccella, N.; Casuscelli, F.; Piperno, A.; Romeo, G. Modified dideoxynucleosides: Synthesis of 2′-N-alkyl-3′-hydroxyalkyl-1′,2′-isoxazolidinyl thymidine and 5-fluorouridine derivatives. Tetrahedron 1996, 52, 8889-8898.
26. Romeo, R.; Giofrè, S.V.; Macchi, B.; Balestrieri, E.; Mastino, A.; Merino, P.; Carnovale, C.; Romeo, G.; Chiacchio, U. Truncated reverse isoxazolidinyl nucleosides: A new class of allosteric HIV-1 reverse transcriptase inhibitors. Chem Med Chem 2012, 7, 565-569.
27. Romeo, R.; Carnovale, C.; Giofrè, S.V.; Romeo, G.; Macchi, B.; Frezza, C.; Marino-Merlo, F.; Pistarà, V.; Chiacchio, U. Truncated phosphonated C-1′-branched N,O-nucleosides: A new class of antiviral agents. Bioorg. Med. Chem. 2012, 20, 3652-3657.
28. Piperno, A.; Giofrè, S.V.; Iannazzo, D.; Romeo, R.; Romeo, G.; Chiacchio, U.; Rescifina, A.; Piotrowska, D.G. Synthesis of C-4′-truncated phosphonated carbocyclic 2′-oxa-3′-azanucleosides as antiviral agents. J. Org. Chem. 2010, 75, 2798-2805.
29. Chiacchio, U.; Rescifina, A.; Iannazzo, D.; Piperno, A.; Romeo, R.; Borrello, L.; Sciortino, M.T.; Balestrieri, E.; Macchi, B.; Mastino, A.; et al. Phosphonated carbocyclic 2′-Oxa-3′-azanucleosides as new antiretroviral agents. J. Med. Chem. 2007, 50, 3747-3750.
30. Chiacchio, U.; Iannazzo, D.; Piperno, A.; Romeo, R.; Romeo, G.; Rescifina, A.; Saglimbeni, M. Synthesis and biological evaluation of phosphonated carbocyclic 2′-oxa-3′-aza-nucleosides. Bioorg. Med. Chem. 2006, 14, 955-959.
31. Chiacchio, U.; Balestrieri, E.; Macchi, B.; Iannazzo, D.; Piperno, A.; Rescifina, A.; Romeo, R.; Saglimbeni, M.; Sciortino, M.T.; Valveri, V.; et al. Synthesis of phosphonated carbocyclic 2′-Oxa-3′-aza-nucleosides: Novel inhibitors of reverse transcriptase. J. Med. Chem. 2005, 48, 1389-1394.
32. Chiacchio, U.; Corsaro, A.; Iannazzo, D.; Piperno, A.; Pistarà, V.; Rescifina, A.; Romeo, R.; Valveri, V.; Mastino, A.; Romeo, G. Enantioselective syntheses and cytotoxicity of N,O-nucleosides. J. Med. Chem. 2003, 46, 3696-3702.
33. Hecker, S.J.; Erion, M.D. Prodrugs of phosphates and phosphonates. J. Med. Chem. 2008, 51, 2328-2345.
34. McGuigan, C.; Derudes, M.; Bugert, J.J.; Andrei, G.; Snoecke, R.; Balzarini, J. Successful kinase bypass with new acyclovir phosphoramidate prodrugs. Bioorg. Med. Chem. Lett. 2008, 18, 4364-4367.
35. He, G.-X.; Krise, J.P.; Oliyai, R. Prodrugs: Challenges and Rewards; Springer: New York, NY, USA, 2007; pp. 223-264.
36. Perrone, P.; Luoni, G.M.; Kelleher, M.R.; Daverio, F.; Angell, A.; Mulready, S.; Congiatu, C.; Rajyageru, S.; Martin, J.A.; Leveque, V.; et al. Application of the phosphoramidate protide approach to 4′-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside. J. Med. Chem. 2007, 50, 1840-1849.
37. Ariza, M.E. Current prodrug strategies for the delivery of nucleotides into cells. Drug Del. Rev. 2005, 2, 273-387.
38. Congiatu, C.; McGuigan, C.; Jiang, W.G.; Davies, G.; Mason, M.D. Naphthyl phosphoramidate derivatives of BVdU as potential anticancer agents: Design, synthesis and biological evaluation. Nucleosides Nucleotides Nucleic Acids 2005, 24, 485-489.
39. McGuigan, C.; Harris, S.A.; Daluge, S.M.; Gudmundsson, K.S.; McLean, E.W.; Burnette, T.C.; Marr, H.; Hazen, R.; Condreay, L.D.; Johnson, L.; et al. Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency. J. Med. Chem. 2005, 48, 3504-3515.
40. Mackman, R.L.; Cihlar, T. Prodrug strategies in the design of nucleoside and nucleotide antiviral therapeutics. Annu. Rep. Med. Chem. 2004, 39, 305-321.
41. Schultz, C. Prodrugs of biologically active phosphate esters. Bioorg. Med. Chem. 2003, 11, 885-898.
42. De Clercq, E. The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond. Biochem. Pharmacol. 2011, 82, 99-109.
43. De Clercq, E.; Holy, A. Acyclic nucleoside phosphonates: A key class of antiviral drugs. Nat. Res. Drug Discov. 2005, 4, 928-940.
44. Deville-Bonne, D.; El Amri, C.; Meyer, P.; Chen, Y.X.; Agrofoglio, L.A. Human and viral nucleoside/nucleotide kinases involved in antiviral drug activation: Structural and catalytic properties. Antivir. Res. 2010, 86, 101-120.
45. De Clercq, E. In search of a selective therapy of viral infections. Antivir. Res. 2010, 85, 19-24.
46. De Clercq, E. Antiviral drug discovery: Ten more compounds, and ten more stories (part B). Med. Res. Rev. 2009, 29, 571-610.
47. Gallier, F.; Alexandre, J.A.C.; El Amri, C.; Deville-Bonne, D.; Peyrotts, S.; Perigaud, C. 5′,6′-Nucleoside phosphonate analogues architecture: Synthesis and comparative evaluation towards metabolic enzymes. Chem Med Chem. 2011, 6, 1094-1106.
48. Meurillon, M.; Gallier, F.; Peyrottes, S.; Périgaud, C. Developing an efficient route to the synthesis of nucleoside1-alkynylphosphonates. Tetrahedron 2009, 65, 6039-6046.
49. Gallier, F.; Peyrottes, S.; Perigaud, C. Ex-chiral-pool synthesis of β-hydroxyphosphonate nucleoside analogues. Eur. J. Org. Chem. 2007, 925-933.
50. Chiacchio, U.; Corsaro, A.; Iannazzo, D.; Piperno, A.; Procopio, A.; Rescifina, A.; Romeo, G.; Romeo, R. Intramolecular cycloadditions of α-allyloxycarbonylnitrones: Stereoselective synthesis of 3-amino-2(5H)furanones. J. Org. Chem. 2002, 67, 4380-4383.
51. Chiacchio, U.; Corsaro, A.; Pistarà, V.; Rescifina, A.; Romeo, G.; Romeo, R. An asymmetric approach to pyrrolidinone and pyrrolizidinone systems by intramolecular oxime-olefin cycloaddition. Tetrahedron 1996, 52, 7875-7884.
52. Hutt, A.J. Drug chirality and its pharmacological consequences. In Introduction to the Principles of Drug Design and Action; Smith, H.J., Williams, H., Eds.; CRC Press: Boca Raton, FL, USA, 2006; pp. 117-183.
53. Carnovale, C.; Iannazzo, D.; Nicolosi, G.; Piperno, A.; Sanfilippo, C. Preparation of isoxazolidinyl nucleoside enantiomers by lipase-catalysed kinetic resolution. Tetrahedron Asymmetry 2009, 20, 425-430.
54. Gervaix, A.; West, D.; Leoni, L.M.; Richman, D.D.; Wong-Staal, F.; Corbeil, J. A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. Proc. Natl. Acad. Sci. USA 1997, 94, 4653-4658.
55. Balestrieri, E.; Pizzimenti, F.; Ferlazzo, A.; Giofrè, S.V.; Iannazzo, D.; Piperno, A.; Romeo, R.; Chiacchio, M.A; Mastino, A.; Macchi, B. Antiviral activity of seed extract from Citrus bergamia towards human retroviruses. Bioorg. Med. Chem. 2011, 19, 2084-2089.